IDEAYA Biosciences, Inc. current report, 09 May 2023

Business Context and Reporting Period

Company: IDEAYA Biosciences, Inc. (IDYA)
Filing Type: Form 8-K (Current Report)
Report Date: May 9, 2023
Reporting Period: First Quarter ended March 31, 2023
Context: The filing announces the Company's financial results for the first quarter of 2023. The detailed results are contained in a press release furnished as Exhibit 99.1.

Key Financial Metrics

The provided text is a cover page and index for the Form 8-K and does not contain specific financial data. The following metrics are not present in the source text:

  • Revenue
  • Net Profit/Loss
  • Cash Flow
  • Profit Margins
  • Debt Levels
  • Liquidity Position

Note: Specific values for these metrics are not provided in the filing text; they are referenced as being available in the attached Exhibit 99.1 (Press Release).

Material Changes

The filing text does not provide specific data regarding material changes in financial performance compared to the prior comparable period. It only confirms the announcement of Q1 2023 results.

Guidance, Outlook, and Risks

Management Commentary: The filing references a press release (Exhibit 99.1) for the full announcement but does not include management commentary, forward-looking guidance, or specific risk factors within the text provided.
Unusual Items: No unusual items are described in the provided text.
Legal Status: The information in Item 2.02 and Exhibit 99.1 is furnished and not deemed "filed" under Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.

Investor Verification Checklist

  • Review Exhibit 99.1 (Press Release dated May 9, 2023) for actual revenue, cash burn, and net loss figures.
  • Verify the Company's cash runway and liquidity position as detailed in the full press release.
  • Check for any updates on clinical trial progress or regulatory milestones mentioned in the full announcement.
  • Confirm if the Company has elected to use the extended transition period for new accounting standards (indicated as an emerging growth company).